Lilly’s blockbuster Zepbound prevents type 2 diabetes in obese patients
The recent data showed a 94% reduction in risk of developing type 2 diabetes after three years of treatment with Zepbound.
21 August 2024
21 August 2024
The recent data showed a 94% reduction in risk of developing type 2 diabetes after three years of treatment with Zepbound.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.